152 related articles for article (PubMed ID: 37829384)
1. Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9848563. PubMed ID: 37829384
[TBL] [Abstract][Full Text] [Related]
2. The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737.
Tang L; Zhang Y; Zhou Q; Hong Q; Wang Z
J Healthc Eng; 2022; 2022():2608633. PubMed ID: 35368955
[TBL] [Abstract][Full Text] [Related]
3. Retracted: A Study on Curcumol Influencing Proliferation and Apoptosis of Hepatocellular Carcinoma Cells through DJ-1/PTEN/PI3K/AKT Pathway.
International BR
Biomed Res Int; 2024; 2024():9781784. PubMed ID: 38230006
[TBL] [Abstract][Full Text] [Related]
4. Tg737 acts as a key driver of invasion and migration in liver cancer stem cells and correlates with poor prognosis in patients with hepatocellular carcinoma.
You N; Tan Y; Zhou L; Huang X; Wang W; Wang L; Wu K; Mi N; Li J; Zheng L
Exp Cell Res; 2017 Sep; 358(2):217-226. PubMed ID: 28663060
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
International BR
Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
[TBL] [Abstract][Full Text] [Related]
7. Structure and expression of Tg737, a putative tumor suppressor gene, in human hepatocellular carcinomas.
Bonura C; Paterlini-Brechot P; Brechot C
Hepatology; 1999 Sep; 30(3):677-81. PubMed ID: 10462374
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9781974. PubMed ID: 37547638
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity of the tumor suppressor gene Tg737 in the side population cells of hepatocellular carcinomas is associated with poor prognosis.
Song Z; Li R; You N; Tao K; Dou K
Mol Biol Rep; 2010 Dec; 37(8):4091-101. PubMed ID: 20300861
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9894384. PubMed ID: 37810563
[TBL] [Abstract][Full Text] [Related]
11. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
Markers D
Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
[TBL] [Abstract][Full Text] [Related]
12. Retracted: LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9789637. PubMed ID: 37387927
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9783892. PubMed ID: 37772007
[TBL] [Abstract][Full Text] [Related]
15. [Retracted] KIFC1 promotes the proliferation of hepatocellular carcinoma
Wang X; Wang M; Li XY; Li J; Zhao DP
Oncol Lett; 2023 Aug; 26(2):345. PubMed ID: 37427345
[TBL] [Abstract][Full Text] [Related]
16. Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
International BR
Biomed Res Int; 2021; 2021():1916343. PubMed ID: 33728325
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9853278. PubMed ID: 37266250
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies.
BioMed Research International
Biomed Res Int; 2018; 2018():4560161. PubMed ID: 29854758
[TBL] [Abstract][Full Text] [Related]
19. Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies.
BioMed Research International
Biomed Res Int; 2016; 2016():2514067. PubMed ID: 27127781
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9808276. PubMed ID: 37503372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
